ACV conversion by HHVs into an anti-HIV-1 drug provides the basis for a new principle of anti-HIV therapy: a 'binary weapon' in which an inert compound is converted by an endogenous component into ...
from Health Canada to begin clinical trials for new label claim applications of its recently Health Canada approved Multiplo® TP/HIV rapid test. These applications include use as a self-test and for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback